I'm

Dr. M. Deenadayalan

HOD and Clinical Lead

Dept. of Paediatric Haematology, Oncology, Blood and Marrow Transplantation MGM Cancer Institute and MGM Healthcare, Chennai

img
svg-iconsvg-iconsvg-iconsvg-icon
image
  • Name

    Dr. M. Deenadayalan
  • Postion

    HOD and Clinical Lead
  • Mail

    drdeenadayalanm@gmail.com
About Me

Biography

Dr. M. Deenadayalan is an esteemed Paediatric Haematologist and Oncologist known for his exceptional clinical skills and extensive experience in treating a range of paediatric conditions. With over 18 years in the field, he specializes in benign blood disorders, malignant haematology (including leukaemia and lymphoma), immunodeficiencies and solid tumours such as neuroblastoma, germ cell tumours, sarcoma, hepatoblastoma, and brain tumours.

He has received training from prestigious institutions across the world in Taiwan, UK, and USA. He has been instrumental in setting up Bone Marrow Transplant units in 4 different hospitals and performing more than 700 Allogeneic and Autologous Stem Cell Transplants to date. He has a vision of incorporating Cellular and Immunotherapy into routine clinical practice.

His dedication to advancing medical care and his compassionate approach make him a respected figure in the medical community and a trusted healthcare provider for his patients and their families. The goal of his team is curative and compassionate care at an affordable cost.

Qualifications

Areas of Expertise

  • FNB - Paediatric Haematology-Oncology

    National Board of Examination, New Delhi
    May 2011

  • FNB- Paediatric Haematology-Oncology

    PHO Chapter- Indian Academy of Paediatrics
    Jan 2010

  • DNB-Paediatrics

    National Board of Examination, New Delhi
    May 2001

  • Diploma in Child Health

    Kasturba Medical College, Manipal (MAHE), Karnataka
    June 1998

  • M.B.B.S

    PSG Inst of Medical Sciences,The Tamil Nadu Dr. MGR Medical University, Chennai (India)
    January 1995

  • MNAMS

    National Academy of Medical Sciences, New Delhi
    May 2002

Experience

Past Professional Experience

  • Senior Consultant and Clinical Lead

    Dept. of Pediatric Hematology, Oncology and BMT Dr. Rela Institute and Medical Centre

    Chennai2019 - 2024
  • Senior Consultant and Clinical Lead

    Dept. of Pediatric Hematology-Oncology and BMT Gleneagles Global Health City

    Chennai2015 - 2019
  • Consultant

    Dept. of Pediatric Hematology-Oncology Apollo Speciality Hospital

    Chennai2012 - 2015
  • Senior Registrar/Junior Consultant

    Department of Pediatric Hemato-oncology, Apollo Speciality Hospital

    Chennai2006 - 2011
  • Registrar/Junior Consultant

    General Paediatrics Kanchi Kamakoti CHILDS Trust Hospital

    Chennai 2001 - 2006

Additional training and Experience

  • image

    Training in unrelated cord blood transplantation at Chang Gung Memorial Hospital, Taiwan

  • image

    Training in Bone Marrow Transplant Unit at Great Ormond Street Hospital for Children in London, United Kingdom

  • image

    Training in Paediatric Haematology/ BMT Department at Children’s Hospital of Pittsburgh of UPMC in Pittsburgh, Pennsylvania, USA.

Awards

Achievements and Recognitions

  • image

    2022: AB-PMJAY award from Govt. of Andhra Pradesh for performing maximum number of BMT for patients from AP under Aarogyasri scheme, in Tamil Nadu, with excellent outcomes.

  • image

    2023: Times Health award for Service Excellence in Paediatric Haematology/Oncology and BMT.

Overview of Research Topics

Paper Presentations

  • Clinico- immunological profile of primary immunodeficiency disease in Teritary care children hospital

    in South India in 3rd Asia Pacific society for immunodeficiencies Chandigarh, India
  • Autolymphoproliferative like presentation in a child with Novel LRBA defect in South India

    3rd Asia Pacific society for immunodeficiencies Chandigarh, India
  • Evans syndrome as a primary presentation of a novel WAS mutant Wiskott Aldrich Syndrome in South India

    3rd Asia Pacific society for immunodeficiencies Chandigarh
  • LRBA mutation- Single center experience and literature in South India

    in 3rd Asia Pacific society for immunodeficiencies - Chandigarh, India
  • Clinico-immunological profile of primary immunodeficiency diseases at a tertiary care children’s hospital in South India

    PHOCON 2018, Bengaluru
  • A descriptive analysis of primary immunodeficiencies in a children’s hospital in Southern India in

    CIDSCON 2018, Vellore.
  • Hemophagocytic lymphohistiocytosis in children: a single center experience.

    Tamil Nadu State Conference TRY PEDICON 2018
  • Multidisciplinary management of hepatoblastoma in children – Experience from South India

    PHOCON 2016, Pune
  • Irinotecan as a maintenance therapy in relapsed Hepatoblastoma-a case report

    PHOCON Mumbai in November 2016
  • Role of Liver Transplantation in Hepatoblastoma – Experience from a Developing Country

    St Jude Viva Forum Singapore 2017
  • Childhood Relapsed Acute Lymphoblastic Leukaemia – Outcome Analysis from a Single Centre 10th ST.JUDE VIVA forum.

    Paediatric Oncology Singapore 2016
  • 12. Haematopoietic Stem Cell Transplantation for Childhood Acute Lymphoblastic Leukaemia - A Single Centre Experience

    10th ST.JUDE VIVA forum Paediatric Oncology Singapore 2016
Works

Publications

  • A Single Centre Experience of Effective Desensitization Strategy for Children with High Anti-HLA Donor-Specific Antibodies Undergoing Haploidentical Hematopoietic Stem Cell Transplantation.

    Indian Journal of Hematology and Blood Transfusion. 2023 Jun 20:1-5
  • Clinical Profile of Hepatitis Associated Aplastic Anemia (HAAA) in Six Children.

    Indian Pediatrics. 2023 May;60(5):410-1.
  • Pre-Transplant Immunosuppression for High Risk Thalassaemia: A Ray of Hope.

    Indian Journal of Hematology and Blood Transfusion. 2023 Jan;39(1):161-2.
  • Mendelian Susceptibility to Mycobacterial Disease Masquerading as Lymphoproliferative Disorder.

    Journal of Applied Hematology. 2020 Jul 1;11(3):145.
  • X-linked Lymphoproliferative Disease (XLP1) Presenting as Non-Epstein Barr Virus (EBV) - Related Hemophagocytic Lymphohistiocytosis (HLH).

    Indian Pediatrics. 2020 Nov 15;57(11):1077-1078.
  • X-linked Lymphoproliferative Disease (XLP1) Presenting as Non-Epstein Barr Virus (EBV) - Related Hemophagocytic Lymphohistiocytosis (HLH).

    Indian Pediatrics. 2020 Nov 15;57(11):1077-1078.
  • Clinical, Immunological, and Molecular Features of Severe Combined Immune Deficiency: A multi-institutional experience from India.

    Frontiers in immunology. 2021 Feb 8;11:619146.
  • The spectrum of clinical, immunological and molecular findings in Familial hemophagocytic lymphohistiocytosis (FHL)

    Frontiers in Immunology. 2021 Mar 5;12:612583.
  • Clinical, immunological, and molecular profile of Chronic Granulomatous Disease: A multicentric study of 236 patients from India.

    Frontiers in immunology. 2021 Feb 25;12:625320.
  • Clinical and Genetic Spectrum of a Large Cohort of Patients With Leukocyte Adhesion Deficiency Type 1 and 3: A Multicentric Study From India.

    Frontiers in Immunology. 2020 Dec 16;11:612703.
  • Prolidase Deficiency in Very Early Onset Inflammatory Bowel Disease (VEO-IBD). Indian Journal of Pediatrics.

    Indian Journal of Pediatrics. 2021 May;88:503-.
  • Varied clinical manifestations of LRBA protein deficiency (Immune dysregulation disorder) – A case series.

    Indian Pediatrics. 2021 Mar;58:285-6.
Memberships

Professional Memberships

  • imageIndian Academy of Paediatrics (Life member)
  • imagePaediatric Haematology and Oncology Chapter – IAP (Life member)

Authored textbook chapters

  • imageAcute Lymphoblastic Leukaemia. PG Textbook of Pediatrics. 1st ed. Jaypee Brothers;. p.2420-2426.
  • imageMegaloblastic anemia. IAP Standard Treatment Guidelines 2022.